Exploring NFkB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality

• 主要な著者: Mubarak Muhammad (著者), Tasneem M. Hassan (著者), Sani S. Baba (著者), Mustapha I. Radda (著者), Mubarak M. Mutawakkil (著者), Majida A. Musa (著者), Sazaly AbuBakar (著者), Shih Keng Loong (著者), Ibrahim Yusuf (著者)
• フォーマット: 図書
• 出版事項: AOSIS, 2022-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

The pandemic of coronavirus disease 2019 (COVID-19), for which there does not appear to be an approved cure, the primary treatment options consist of non-pharmacological preventive measures and supportive treatment that are aimed at halting the progression of the disease. Nuclear factor kappa B (NFk...